[Chronic suppurative bronchopathy and motility defect of neutrophils: evaluation of an immunomodulating treatment].
Five patients with recurrent infections of the lower respiratory tract, chronic bronchial suppuration and significant defect of polymorphonuclear granulocyte (PMN) motility were studied. Clinical evaluation and in vitro studies of PMN motility were performed before, during and after the treatment with levamisole chlorhydrate (2.5 mg/Kg twice a week). Clinical improvement was obtained in all the patients, together with a significant increase in the chemotactic response of PMN. No side effects were reported. After a follow-up of 7-18 months PMN chemotaxis remained normal in all the patients and a reappearance of respiratory symptoms was observed only in one subject.
Cazzola
G A
GA
Servizio Pediatrico Speciale, Ospedale Civile Maggiore - Verona, Italia.
Valletta
E A
EA
Mastella
G
G
D000293:Adolescent; D000328:Adult; D001982:Bronchial Diseases / Q000628:therapy*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007978:Levamisole / Q000031:analogs & derivatives / Q000627:therapeutic use*; D009504:Neutrophils; D012008:Recurrence; D012189:Retrospective Studies
D007978:Levamisole
Broncopatia suppurativa cronica e difetto di motilità dei neutrofili: valutazione di un trattamento immunomodulante.